Ecotrin Related Published Studies
Well-designed clinical trials related to Ecotrin (Aspirin)
Low-Dose Aspirin and Medical Record-Confirmed Age-Related Macular Degeneration in a Randomized Trial of Women. [2009.10.06]
Time-Dependent Effects of Low-Dose Aspirin on Plasma Renin Activity, Aldosterone, Cortisol, and Catecholamines. [2009.10.05]
Randomized controlled trial of aspirin and clopidogrel versus aspirin and placebo on markers of smooth muscle proliferation before and after peripheral angioplasty. [2009.10]
Platelet inhibitory effects of OTC doses of naproxen sodium compared with prescription dose naproxen sodium and low-dose aspirin. [2009.10]
Lower incidence of hypertensive complications during pregnancy in patients treated with low-dose aspirin during in vitro fertilization and early pregnancy. [2009.10]
Preliminary trial of rebamipide for prevention of low-dose aspirin-induced gastric injury in healthy subjects: a randomized, double-blind, placebo-controlled, cross-over study. [2009.09]
Aspirin Use and the Risk of Gastric Cancer: A Meta-Analysis. [2009.08.12]
Sarpogrelate versus aspirin in secondary prevention of cerebral infarction: differential efficacy in diabetes? Subgroup analysis from S-ACCESS. [2009.08]
Ambulatory blood pressure control with bedtime aspirin administration in subjects with prehypertension. [2009.08]
Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial. [2009.07.11]
Clopidogrel and aspirin versus clopidogrel alone on graft patency after coronary artery bypass grafting. [2009.07]
Effect of aspirin on hypothalamic-pituitary-adrenal function and on neuropsychological performance in healthy adults: a pilot study. [2009.07]
Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: results from the double-blind, prospective, randomized Tailoring Treatment with Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel study. [2009.06.30]
Parnaparin versus aspirin in the treatment of retinal vein occlusion. A randomized, double blind, controlled study. [2009.05.26]
Effect of dipyridamole plus aspirin on hemodialysis graft patency. [2009.05.21]
Clinical outcomes of patients with diabetic nephropathy randomized to clopidogrel plus aspirin versus aspirin alone (a post hoc analysis of the clopidogrel for high atherothrombotic risk and ischemic stabilization, management, and avoidance [CHARISMA] trial). [2009.05.15]
A randomized, controlled study on the influence of acetaminophen, diclofenac, or naproxen on aspirin-induced inhibition of platelet aggregation. [2009.05.01]
Cross validation of aspirin effect in healthy individuals by Impact-R and PFA-100: a double blind randomized placebo controlled trial. [2009.05]
No effect of aspirin on mammographic density in a randomized controlled clinical trial. [2009.05]
Combined aspirin and cilostazol treatment is associated with reduced platelet aggregation and prevention of exercise-induced platelet activation. [2009.05]
Cilostazol in addition to aspirin and clopidogrel improves long-term outcomes after percutaneous coronary intervention in patients with acute coronary syndromes: a randomized, controlled study. [2009.04]
Effects of aspirin when added to the prostaglandin D2 receptor antagonist laropiprant on niacin-induced flushing symptoms. [2009.04]
Aspirin use and risk of type 2 diabetes in apparently healthy men. [2009.04]
Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial. [2009.03.31]
Aspirin to prevent cardiovascular disease: the association of aspirin dose and clopidogrel with thrombosis and bleeding. [2009.03.17]
Low-dose aspirin therapy to prevent ovarian hyperstimulation syndrome. [2009.03.02]
Assessment of P2Y(12) inhibition with the point-of-care device VerifyNow P2Y12 in patients treated with prasugrel or clopidogrel coadministered with aspirin. [2009.03]
Prolonged anticoagulation therapy adjunctive to aspirin after successful fibrinolysis: from early reduction in reocclusion to improved long-term clinical outcome. [2009.03]
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance". [2009.02.24]
Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials. [2009.02.18]
Nonsteroidal anti-inflammatory drug use after 3 years of aspirin use and colorectal adenoma risk: observational follow-up of a randomized study. [2009.02.18]
Does low-dose aspirin improve pregnancy rate in IVF/ICSI? A randomized double-blind placebo controlled trial. [2009.01.08]
Randomized trial comparing 600- with 300-mg loading dose of clopidogrel in patients with non-ST elevation acute coronary syndrome undergoing percutaneous coronary intervention: results of the Platelet Responsiveness to Aspirin and Clopidogrel and Troponin Increment after Coronary intervention in Acute coronary Lesions (PRACTICAL) Trial. [2009.01]
A randomized trial of low-dose aspirin in the prevention of clinical type 2 diabetes in women. [2009.01]
Incidence of small bowel injury induced by low-dose aspirin: a crossover study using capsule endoscopy in healthy volunteers. [2009]
Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome. [2008.12.11]
Design and rationale of CURRENT-OASIS 7: a randomized, 2 x 2 factorial trial evaluating optimal dosing strategies for clopidogrel and aspirin in patients with ST and non-ST-elevation acute coronary syndromes managed with an early invasive strategy. [2008.12]
The effects of aspirin and clopidogrel response on myonecrosis after percutaneous coronary intervention: a BRIEF-PCI (Brief Infusion of Intravenous Eptifibatide Following Successful Percutaneous Coronary Intervention) trial substudy. [2008.12]
[Effects of puerarin with aspirin on the markers of damaged vascular endothelial cells in patients with acute cerebral infarction] [2008.12]
Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial. [2008.11.12]
Low-dose aspirin in non-tubal IVF patients with previous failed conception: a prospective randomized double-blind placebo-controlled trial. [2008.10.28]
The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease. [2008.10.16]
A Randomized Trial of Low-Dose Aspirin in the Prevention of Clinical Type 2 Diabetes in Women. [2008.10.03]
Efficacy of esomeprazole (20 mg once daily) for reducing the risk of gastroduodenal ulcers associated with continuous use of low-dose aspirin. [2008.10]
Platelet activity and aspirin efficacy after off-pump compared with on-pump coronary artery bypass surgery: results from the prospective randomized trial PRAGUE 11-Coronary Artery Bypass and REactivity of Thrombocytes (CABARET). [2008.10]
Bleeding time prolonged by daily low-dose aspirin is shortened by one medium dose aspirin. [2008.10]
Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study. [2008.10]
Comparison of oral aspirin versus topical applied methyl salicylate for platelet inhibition. [2008.10]
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. [2008.09.18]
Low dose aspirin and cognitive function in middle aged to elderly adults: randomised controlled trial. [2008.09.01]
Renal effects of aspirin are clearly dose-dependent and are of clinical importance from a dose of 160 mg. [2008.09]
Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease. [2008.08.26]
Comparison of increased aspirin dose versus combined aspirin plus clopidogrel therapy in patients with diabetes mellitus and coronary heart disease and impaired antiplatelet response to low-dose aspirin. [2008.08.15]
A randomised controlled trial of triple antiplatelet therapy (aspirin, clopidogrel and dipyridamole) in the secondary prevention of stroke: safety, tolerability and feasibility. [2008.08.06]
Inhibition of platelet aggregation by combined therapy with aspirin and cilostazol after off-pump coronary artery bypass surgery. [2008.08]
Effects of aspirin and clopidogrel in healthy men measured by platelet aggregation and PFA-100. [2008.08]
Aspirin use and post-operative bleeding from dental extractions. [2008.08]
Low-dose aspirin may prevent growth and later surgical repair of medium-sized abdominal aortic aneurysms. [2008.08]
Vitamins B2, B6, and B12 and risk of new colorectal adenomas in a randomized trial of aspirin use and folic acid supplementation. [2008.08]
Aspirin and clopidogrel treatment impair nitric oxide biosynthesis by platelets. [2008.08]
Tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel (3T/2R). Rationale for the study and protocol design. [2008.08]
An assessment of the joint associations of aspirin and statin use with C-reactive protein concentration. [2008.07]
Dalteparin versus Aspirin in Recent-Onset Branch Retinal Vein Occlusion: A Randomized Clinical Trial. [2008.07]
Aspirin, clopidogrel, and warfarin: is the combination appropriate and effective or inappropriate and too dangerous? [2008.06]
Sarpogrelate-Aspirin Comparative Clinical Study for Efficacy and Safety in Secondary Prevention of Cerebral Infarction (S-ACCESS): A randomized, double-blind, aspirin-controlled trial. [2008.06]
Switching directly to prasugrel from clopidogrel results in greater inhibition of platelet aggregation in aspirin-treated subjects. [2008.06]
Cilostazol as an alternative to aspirin after ischaemic stroke: a randomised, double-blind, pilot study. [2008.06]
Effects of policosanol (10 mg/d) versus aspirin (100 mg/d) in patients with intermittent claudication: a 10-week, randomized, comparative study. [2008.06]
Randomised aspirin assignment and risk of adult-onset asthma in the Women's Health Study. [2008.06]
Risks and benefits of oral anticoagulation compared with clopidogrel plus aspirin in patients with atrial fibrillation according to stroke risk: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE-W). [2008.05]
Platelet inhibition by low-dose aspirin but not by clopidogrel reduces the axon-reflex current-induced vasodilation in humans. [2008.05]
Effect of aspirin on airway inflammation and pulmonary function in patients with persistent asthma. [2008.05]
Meta-Analysis of the Efficacy and Safety of Clopidogrel Plus Aspirin as Compared to Antiplatelet Monotherapy for the Prevention of Vascular Events. [2008.04.01]
The antiplatelet effect of six non-steroidal anti-inflammatory drugs and their pharmacodynamic interaction with aspirin in healthy volunteers. [2008.04.01]
The effect of pre-operative aspirin on bleeding, transfusion, myocardial infarction, and mortality in coronary artery bypass surgery: a systematic review of randomized and observational studies. [2008.04]
Effect of tirofiban plus clopidogrel and aspirin on primary percutaneous coronary intervention via transradial approach in patients with acute myocardial infarction. [2008.03.20]
The effect of pre-operative aspirin on bleeding, transfusion, myocardial infarction, and mortality in coronary artery bypass surgery: a systematic review of randomized and observational studies. [2008.03.16]
Rapid protection of the gastroduodenal mucosa against aspirin-induced damage by rabeprazole. [2008.03.15]
Low-dose aspirin and breast cancer risk: results by tumour characteristics from a randomised trial. [2008.03.11]
The effects of aspirin and nonselective beta blockade on the acute prothrombotic response to psychosocial stress in apparently healthy subjects. [2008.03]
Aspirin and Tranexamic Acid for Coronary Artery Surgery (ATACAS) Trial: rationale and design. [2008.02]
Aspirin, but not propranolol, attenuates the acute stress-induced increase in circulating levels of interleukin-6: a randomized, double-blind, placebo-controlled study. [2008.02]
Patient-directed intervention versus clinician reminders alone to improve aspirin use in diabetes: a cluster randomized trial. [2008.02]
Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study. [2008.01.22]
Effect of long-term aspirin use on embolic events in infective endocarditis. [2008.01.01]
Effects of clopidogrel and aspirin in combination versus aspirin alone on platelet activation and major receptor expression in diabetic patients: the PLavix Use for Treatment Of Diabetes (PLUTO-Diabetes) trial. [2008.01]
Magnitude and time course of platelet inhibition with extended release dipyridamole with or without aspirin in healthy Japanese volunteers. The AGgrenox versus Aspirin Therapy Evaluation (AGATE-Japan). [2008.01]
Safety of triflusal (antiplatelet drug) in patients with aspirin-exacerbated respiratory diseases. [2008.01]
Aspirin and folic acid for the prevention of recurrent colorectal adenomas. [2008.01]
Effects of aspirin and propranolol on the acute psychological stress response in factor VIII coagulant activity: a randomized, double-blind, placebo-controlled experimental study. [2008.01]
Effects of Ibuprofen on the Magnitude and Duration of Aspirin's Inhibition of Platelet Aggregation: Clinical Consequences in Stroke Prophylaxis. [2008.01]
Prasugrel achieves greater and faster P2Y12receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease. [2008.01]
Population pharmacodynamic modelling of aspirin- and Ibuprofen-induced inhibition of platelet aggregation in healthy subjects. [2008]
Clopidogrel and aspirin versus aspirin alone for the prevention of stroke in patients with a history of atrial fibrillation: subgroup analysis of the CHARISMA randomized trial. [2008]
Effect of Ginkgo biloba (EGb 761) and aspirin on platelet aggregation and platelet function analysis among older adults at risk of cardiovascular disease: a randomized clinical trial. [2007.12]
Effect of clopidogrel treatment on stress-induced platelet activation and myocardial ischemia in aspirin-treated patients with stable coronary artery disease. [2007.12]
Effects of aspirin on serum C-reactive protein and interleukin-6 levels in patients with type 2 diabetes without cardiovascular disease: a randomized placebo-controlled crossover trial. [2007.11.22]
Dabigatran with or without concomitant aspirin compared with warfarin alone in patients with nonvalvular atrial fibrillation (PETRO Study). [2007.11.01]
Polymorphisms in PTGS1, PTGS2 and IL-10 do not influence colorectal adenoma recurrence in the context of a randomized aspirin intervention trial. [2007.11.01]
Comparing warfarin to aspirin (WoA) after aortic valve replacement with the St. Jude Medical Epic heart valve bioprosthesis: results of the WoA Epic pilot trial. [2007.11]
The influence of gender on the effects of aspirin in preventing myocardial infarction. [2007.10.18]
|
